Rockefeller Capital Management
TLSIW icon

Rockefeller Capital Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Rockefeller Capital Management’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60 Buy
+50
New +$67 ﹤0.01% 4650

Other funds holding TLSIW

Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Rockefeller Capital Management's TLSIW Position: Q1 2026 in Review

Rockefeller Capital Management opened a new position in TriSalus Life Sciences Warrant (TLSIW) in Q1 2026: 50 shares worth $60. The stake represents ﹤0.01% of the portfolio and ranks #4650 among its holdings.

7 funds tracked by Wall St. Rank hold TLSIW as of Q1 2026.

  • Rockefeller Capital Management held 50 shares of TriSalus Life Sciences Warrant worth $60 as of Q1 2026.
  • TriSalus Life Sciences Warrant was a new Rockefeller Capital Management position in Q1 2026.
  • TriSalus Life Sciences Warrant made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4650 holding.
  • 7 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.